GRANULES vs LAURUSLABS: Stock Comparison

Granules India Limited vs Laurus Labs LimitedUpdated 21 Aug 26, 4:08 PM ISTNSE & company filings

Laurus Labs Limited is the larger company by market capitalisation. Granules India Limited shows a lower P/E, a higher dividend yield and faster revenue growth, while Laurus Labs Limited shows a higher ROE, a higher ROCE and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

GRANULES leads 9; LAURUSLABS leads 4 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

GRANULESLAURUSLABS

Valuation lens

What price are you paying?

Market CapContext only
₹21,277 Cr
₹96,799 Cr
P/E RatioGRANULES has the lower reading
31.82x
89.61x
P/B RatioGRANULES has the lower reading
4.18x
18.48x
EPSGRANULES has the higher reading
₹26.95
₹16.46
Book ValueContext only
₹205.21
₹98.16
Dividend YieldGRANULES has the higher reading
0.2%
0.19%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
LAURUSLABS is the larger company
₹96,799 Cr vs ₹21,277 Cr
P/E Ratio
GRANULES has a lower P/E
31.82x vs 89.61x
P/B Ratio
GRANULES has a lower P/B
4.18x vs 18.48x
EPS
GRANULES has higher earnings per share
₹26.95 vs ₹16.46
Dividend Yield
GRANULES has a higher dividend yield
0.2% vs 0.19%
Revenue Growth (TTM YoY)
GRANULES has faster revenue growth
22.8% vs 5.3%
EPS Growth (TTM YoY)
GRANULES has faster EPS growth
31.3% vs 19.4%
Qtr Sales Growth
GRANULES has stronger quarterly sales growth
22.8% vs 5.31%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricGRANULESLAURUSLABS
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricGRANULESLAURUSLABS
Live Price₹858.15₹1,802
Day Change1.97%-1.26%
Volume4.06 L14.02 L
52-Week High₹910₹1,870.8
52-Week Low₹454.75₹823.1
Distance from 52W High-5.7%-3.68%

Valuation

MetricGRANULESLAURUSLABS
Market Cap₹21,277 Cr₹96,799 Cr
P/E Ratio31.82x89.61x
P/B Ratio4.18x18.48x
EPS₹26.95₹16.46
Book Value₹205.21₹98.16
Dividend Yield0.2%0.19%

Growth

MetricGRANULESLAURUSLABS
Revenue Growth (TTM YoY)22.8%5.3%
EPS Growth (TTM YoY)31.3%19.4%
Qtr Sales Growth22.8%5.31%
Qtr Profit Growth44.6%19.5%

Profitability & Leverage

MetricGRANULESLAURUSLABS
ROE13.7%18.3%
ROCE15.5%17.8%
Net Margin11.15%13.76%
Operating Margin22.1%26.2%
Debt to Equity0.3x0.48x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricGRANULESLAURUSLABS
Promoter Holding37.67%27.47% 0.02 pp
FII Holding17.5% 2.19 pp28% 2.18 pp
DII Holding16.11% 0.9 pp13.74% 0.23 pp
Public Holding28.38% 1.28 pp30.78% 1.93 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Granules India Limited and Laurus Labs Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.